Skip to main content
. 2012 Apr 18;2012(4):CD003869. doi: 10.1002/14651858.CD003869.pub3
Trial name or title Protocol ID: P03247 Temozolomide for treatment of brain metastases from non‐small cell lung cancer
Methods
Participants 1. histologically confirmed non‐small cell lung cancer 2. at least one brain metastases 3. no previous WBRT or radiosurgery 4. no more than two sites of extracranial disease 5. KPS greater than 70
Interventions WBRT plus temozolomide versus WBRT plus placebo
Outcomes 1. survival 2. improvement in time to radiologic CNS progression
Starting date
Contact information
Notes